The Europe Blood Warmer Market would witness market growth of 7.5% CAGR during the forecast period (2023-2030).
Belmont Medical Technologies reported 2020 that early care by helicopter EMS providers can significantly reduce the risk of hypothermia, decreasing or even stopping the trauma triad of death and other issues. For instance, the Danish medical technology company MEQU introduced the Power Pack in December 2020 as a new battery for its M Warmer System, a portable system for warming IV fluids and blood.
The system is frequently utilized in prehospital emergency settings, including ambulances, rescue helicopters, and rapid response vehicles. The M Warmer System, which enables blood infusions at the place of injury in distant regions or on battlefields, has been purchased by Special Forces and military in the U.K., the Netherlands, Germany, France, Sweden, and Denmark. The same source claims that adding IV fluid and blood warmers to ambulatory services and EMS has been associated with a significant decrease in admission hypothermia. Therefore, market growth in the near future will be driven by growth in the ambulatory and military sectors.
A significant element driving the demand is the rise in occurrences of hypothermia-related disorders and the rising prevalence of chronic diseases like thyroid and diabetes. Additionally, as blood warmers are crucial in surgical units, an increase in surgeries is anticipated to enhance the market. Therefore, during the projected period, these factors are expected to benefit the market.
As per the UK governments’ report named “Future of an ageing population”, by 2040, in UK, nearly one in seven people are projected to be aged over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over an increase of 161% over 25 years. The proportion of the working age population aged between 50 and the state pension age (SPA) will increase from 26% in 2012 to 34% in 2050 an increase of over 5.5 million people. Growing ageing population in these regional countries is predicted to result in the rise of the market.
The Germany market dominated the Europe Blood Warmer Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $115.1 million by 2030. The UK market is registering a CAGR of 6.6% during (2023 - 2030). Additionally, The France market would displaY a CAGR of 8.3% during (2023 - 2030).
Based on Application, the market is segmented into Surgery, Acute Care, New Born Care, Homecare, and Others. Based on Product, the market is segmented into Non-portable Blood/IV Warmers, and Portable Blood/IV Warmers. Based on End-use, the market is segmented into Hospitals/Clinic, Ambulatory Services, Defense Forces, and Rescue Forces. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Blood Warmer Market is Projected to reach USD 1.8 Billion by 2030, at a CAGR of 7.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Stryker Corporation, ICU Medical, Inc., Gentherm Incorporated (Gentherm Medical), Vyaire Medical, Inc. (Apax Partners LLP), Belmont Medical Technologies (Audax Management Company, LLC.), The Surgical Company, Life Warmer, Estill Medical Technologies, Inc., and Smisson-Cartledge Biomedical, LLC.
By Application
By Product
By End-use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
